ImmuCell Corporation Amortization of Debt Discount (Premium)
ImmuCell Corporation (ICCC) reported Amortization of Debt Discount (Premium) of $10.45 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2024-08-13
- ImmuCell Corporation amortization of debt discount (premium) for the quarter ending 2024-06-30 was $5.22K.
- ImmuCell Corporation amortization of debt discount (premium) for the quarter ending 2024-03-31 was $5.22K.
- ImmuCell Corporation amortization of debt discount (premium) for the quarter ending 2023-12-31 was $5.22K.
- ImmuCell Corporation amortization of debt discount (premium) for fiscal 2023 was $9.55K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2024-06-30 | $5.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $10.45K 10-Q · filed 2024-08-13 | $15.67K derived: sum of 3 quarters · filed 2024-08-13 | |
| 2024-03-31 | $5.22K 10-Q · filed 2024-05-14 | $10.45K derived: sum of 2 quarters · filed 2024-05-14 | ||
| 2023-12-31 | $5.22K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $9.55K 10-K · filed 2024-04-01 | ||
| 2023-09-30 | $4.32K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |